These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39175216)

  • 1. Cardiogenic shock secondary to immune checkpoint inhibitor associated myocarditis.
    Lee KK; Bain T; Flapan A
    J R Coll Physicians Edinb; 2024 Sep; 54(3):225-230. PubMed ID: 39175216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful management of camrelizumab-induced immune-checkpoint-inhibitors-related myocarditis.
    Long HD; Du YP; Wang LY; Liu GC; Liang SX; Zeng ZH; Lin YE
    J Oncol Pharm Pract; 2024 Apr; 30(3):597-604. PubMed ID: 38043937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.
    Delombaerde D; Vervloet D; Berwouts D; Beckers R; Prenen H; Peeters M; Gremonprez F; Croes L; Vulsteke C
    J Med Case Rep; 2022 Jul; 16(1):275. PubMed ID: 35831829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitor sintilimab-induced lethal myocarditis overlapping with myasthenia gravis in thymoma patient: A case report.
    Wang C; Zhong B; He J; Liao X
    Medicine (Baltimore); 2023 Apr; 102(15):e33550. PubMed ID: 37058040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
    Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
    J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teriprizumab-induced myocarditis in a patient with cholangiocarcinoma: a case report.
    Ye Y; Li Y; Zhang S; Han G
    J Int Med Res; 2022 Oct; 50(10):3000605221133259. PubMed ID: 36300305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H
    Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of lymphocytic myocarditis in a patient treated with an immune checkpoint inhibitor, a recent class of chemotherapy agents.
    Duarte T; Costa C; Gonçalves S; Raposo L; Ferreira A; Albuquerque C; Vau N; Caria R
    Rev Port Cardiol; 2022 Dec; 41(12):1047-1051. PubMed ID: 36257498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocarditis related to immune checkpoint inhibitors treatment: two case reports and literature review.
    Chen Y; Jia Y; Liu Q; Shen Y; Zhu H; Dong X; Huang J; Lu J; Yin Q
    Ann Palliat Med; 2021 Jul; 10(7):8512-8517. PubMed ID: 34263614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant myopericarditis and takotsubo syndrome following immune checkpoint inhibitor therapy.
    Tan NYL; Anavekar NS; Wiley BM
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32878855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature.
    Saad R; Ghaddar A; Zeenny RM
    J Med Case Rep; 2024 Feb; 18(1):107. PubMed ID: 38383436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report.
    Miyauchi Y; Naito H; Tsunemori H; Tani R; Hasui Y; Miyake Y; Minamino T; Ishikawa R; Kushida Y; Haba R; Sugimoto M
    J Med Case Rep; 2021 Oct; 15(1):508. PubMed ID: 34649593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study.
    Nishikawa T; Inoue T; Otsuka T; Kuno I; Kukita Y; Nakamura H; Ikeda Y; Yasui T; Shioyama W; Oka T; Honma K; Hatakeyama K; Miyata H; Isei T; Ishihara R; Kumagai T; Nishimura K; Fujita M
    PLoS One; 2022; 17(11):e0275865. PubMed ID: 36378654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.
    Peleg Hasson S; Salwen B; Sivan A; Shamai S; Geva R; Merimsky O; Raphael A; Shmilovich H; Moshkovits Y; Kapusta L; Rozenbaum Z; Wolf I; Laufer-Perl M
    Clin Res Cardiol; 2021 Jan; 110(1):50-60. PubMed ID: 32296970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients.
    Ansari-Gilani K; Tirumani SH; Smith DA; Nelson A; Alahmadi A; Hoimes CJ; Ramaiya NH
    Emerg Radiol; 2020 Aug; 27(4):455-460. PubMed ID: 32130542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keeping immune checkpoint inhibitor myocarditis in check: advanced circulatory mechanical support as a bridge to recovery.
    Stein-Merlob AF; Hsu JJ; Colton B; Berg CJ; Ferreira A; Price MM; Wainberg Z; Baas AS; Deng MC; Parikh RV; Yang EH
    ESC Heart Fail; 2021 Oct; 8(5):4301-4306. PubMed ID: 34390221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLE strikes the heart! A rare presentation of SLE myocarditis presenting as cardiogenic shock.
    Raval JJ; Ruiz CR; Heywood J; Weiner JJ
    BMC Cardiovasc Disord; 2021 Jun; 21(1):294. PubMed ID: 34120592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors.
    Mladosievičová B; Országhová Z; Jablonická M; Rečková M; Chovanec M; Mego M
    Klin Onkol; 2020; 33(5):350-355. PubMed ID: 33108879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed immune-related neutropenia with hepatitis by pembrolizumab.
    Nakako S; Nakashima Y; Okamura H; Tani Y; Ueda T; Makuuchi Y; Kuno M; Takakuwa T; Nishimoto M; Koh H; Nakamae H; Hino M
    Immunotherapy; 2022 Feb; 14(2):101-105. PubMed ID: 34758635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Glucocorticoid Effect Observation in a Ureteral Urothelial Cancer Patient With ICI-Associated Myocarditis and Multiple Organ Injuries.
    Hu X; Wei Y; Shuai X
    Front Immunol; 2021; 12():799077. PubMed ID: 34975911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.